Scanxiety: Life After Cancer Treatment and the Lingering Fear of What Comes Next

The world goes quiet when treatment ends. No more appointments. No more countdowns to the next infusion. No more late-night Google searches, medication alarms, or labs to monitor every cell in your body. But for Josh, the silence was not peace—it was uncertainty. My brother, Joshua, was diagnosed in November 2024 with Stage 4 non-small cell lung cancer (NSCLC) . A punch to the gut, but even in the chaos, there was a thread of hope. The cancer had not spread to any major organs—only the pleura cavity . Even more promising, Josh had a genetic mutation—EGFR+ , which meant he could be treated with Tagrisso , a targeted therapy with a strong success rate in shrinking tumors. He took the pill every day. No missed doses. He also braved four rounds of chemotherapy . Although the original plan was six, his oncologist was stunned at his progress—the tumor shrank from nearly 7cm to under 2cm . Two rounds were canceled. Everyone called it a miracle. Then came the...